In this community, professionals share information regarding the clinical, programmatic and community-oriented aspects of early diagnosis, treatment and prevention of multi-drug-resistant tuberculosis (MDR-TB). Members also use this forum to promote universal access to quality care for MDR-TB.

Community moderators

Masoud Dara, MD
WHO Europe - EURO
Christopher Gilpin, PhD, MPH
World Health Organization - WHO

Recent community activity

Global Investments in Tuberculosis Research and Development

by Madhukar Pai

All, At the Moscow Ministerial Meeting on TB, WHO released a policy brief that aims to articulate a coherent vision of the research needs to end TB and elaborates on the funding and structural requirements that are necessary to operationalize this vision. URL: http://www.who.int/tb/publications/2017/Global_Investments_in_Tuberculosis_Research_Investment/en/ Also see this related blog post ... read more

Updated: 17 Nov, 2017
Replies: 0

Fwd: Kind request: Support 'My Patient's Choice' pledge

by Erica Lessem

If you are directly or indirectly involved in the care of people with multidrug-resistant TB (MDR-TB), please consider endorsing this pledge to empower people with MDR-TB to choose between the use of a novel drug (currently bedaquiline or delamanid) or an injectable aminoglycoside drug as part of their MDR-TB regimen, ... read more

Updated: 15 Nov, 2017
Replies: 0
Updated: 14 Nov, 2017
Replies: 3
Updated: 11 Nov, 2017
Replies: 2

New community members

User Photo

Prakash Bhattarai

Affiliated Organizations

Sagam Community Hospital

Work Locations

Nepal

User Photo

Geoff Graham

Affiliated Organizations

DNA Genotek Inc.

Work Locations

Canada

User Photo

Parag Karki

Affiliated Organizations

National Academy of Medical Sciences

Work Locations

Nepal